» Articles » PMID: 19205035

Diverse Roles of Invariant Natural Killer T Cells in Liver Injury and Fibrosis Induced by Carbon Tetrachloride

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2009 Feb 11
PMID 19205035
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Liver fibrosis is a common scarring response to all forms of chronic liver injury and is always associated with inflammation that contributes to fibrogenesis. Although a variety of cell populations infiltrate the liver during inflammation, it is generically clear that CD8 T lymphocytes promote while natural killer (NK) cells inhibit liver fibrosis. However, the role of invariant natural killer T (iNKT) cells, which are abundant in the liver, in hepatic fibrogenesis, remains obscure. Here we show that iNKT-deficient mice are more susceptible to carbon tetrachloride (CCl(4))-induced acute liver injury and inflammation. The protective effect of naturally activated iNKT in this model is likely mediated via suppression of the proinflammatory effect of activated hepatic stellate cells. Interestingly, strong activation of iNKT through injection of iNKT activator alpha-galactosylceramide (alpha-GalCer) accelerates CCl(4)-induced acute liver injury and fibrosis. In contrast, chronic CCl(4) administration induces a similar degree of liver injury in iNKT-deficient and wild-type mice, and only a slightly higher grade of liver fibrosis in iNKT-deficient mice than wild-type mice 2 weeks but not 4 weeks after CCl(4) injection, although iNKT cells are able to kill activated stellate cells. An insignificant role of iNKT in chronic liver injury and fibrosis may be attributable to hepatic iNKT cell depletion. Finally, chronic alpha-GalCer treatment had little effect on liver injury and fibrosis, which is attributable to iNKT tolerance after alpha-GalCer injection.

Conclusion: Natural activation of hepatic iNKT cells inhibits, whereas strong activation of iNKT cells by alpha-GalCer accelerates CCl(4)-induced acute liver injury, inflammation, and fibrosis. During chronic liver injury, hepatic iNKT cells are depleted and play a role in inhibiting liver fibrosis in the early stage but not the late stage of fibrosis.

Citing Articles

Gut Microbiome and Bile Acid Interactions: Mechanistic Implications for Cholangiocarcinoma Development, Immune Resistance, and Therapy.

Wu N, Bayatpour S, Hylemon P, Aseem S, Aseem S, Brindley P Am J Pathol. 2024; 195(3):397-408.

PMID: 39730075 PMC: 11841492. DOI: 10.1016/j.ajpath.2024.11.004.


Novel Choline-Deficient and 0.1%-Methionine-Added High-Fat Diet Induces Burned-Out Metabolic-Dysfunction-Associated Steatohepatitis with Inflammation by Rapid Immune Cell Infiltration on Male Mice.

Sakaguchi T, Nagahama Y, Hamada N, Singh S, Mikami H, Maeda K Nutrients. 2024; 16(23).

PMID: 39683544 PMC: 11643772. DOI: 10.3390/nu16234151.


Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells.

Feng X, Feng B, Zhou J, Yang J, Pan Q, Yu J Hepatology. 2024; .

PMID: 38546278 PMC: 11902620. DOI: 10.1097/HEP.0000000000000831.


IRF3 activates RB to authorize cGAS-STING-induced senescence and mitigate liver fibrosis.

Wu Q, Leng X, Zhang Q, Zhu Y, Zhou R, Liu Y Sci Adv. 2024; 10(9):eadj2102.

PMID: 38416816 PMC: 10901380. DOI: 10.1126/sciadv.adj2102.


New and Old Key Players in Liver Cancer.

Cuesta A, Palao N, Bragado P, Gutierrez-Uzquiza A, Herrera B, Sanchez A Int J Mol Sci. 2023; 24(24).

PMID: 38138981 PMC: 10742790. DOI: 10.3390/ijms242417152.


References
1.
Friedman S, Rockey D, Bissell D . Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology. 2006; 45(1):242-9. DOI: 10.1002/hep.21459. View

2.
Sun R, Park O, Horiguchi N, Kulkarni S, Jeong W, Sun H . STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology. 2006; 44(4):955-66. DOI: 10.1002/hep.21344. View

3.
Minagawa M, Deng Q, Liu Z, Tsukamoto H, Dennert G . Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology. 2004; 126(5):1387-99. DOI: 10.1053/j.gastro.2004.01.022. View

4.
Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y . Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol. 2007; 19(8):1021-9. DOI: 10.1093/intimm/dxm069. View

5.
Wintermeyer P, Cheng C, Gehring S, Hoffman B, Holub M, Brossay L . Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage. Gastroenterology. 2008; 136(3):1048-59. PMC: 2654188. DOI: 10.1053/j.gastro.2008.10.027. View